Metabolic Explorer Stock | METEX.PA | FR0004177046 | A0MN12

Date	Metabolic Explorer Price
10/7/2024	0.12 undefined
10/4/2024	0.12 undefined

Date	Metabolic Explorer Revenue	Metabolic Explorer EBIT	Metabolic Explorer Net Income
2026e	425.9 M undefined	32.16 M undefined	73.14 M undefined
2025e	260.59 M undefined	7.21 M undefined	-4.72 M undefined
2024e	198.79 M undefined	-10.3 M undefined	-20.45 M undefined
2023e	135.96 M undefined	-31.93 M undefined	-43.01 M undefined
2022	226.6 M undefined	-43.76 M undefined	-50.83 M undefined
2021	169.69 M undefined	73.04 M undefined	82.62 M undefined
2020	50,000 undefined	-9.65 M undefined	-8.93 M undefined
2019	350,000 undefined	-8.38 M undefined	-8.25 M undefined
2018	3.31 M undefined	-5.03 M undefined	-6.14 M undefined
2017	4.04 M undefined	-11.1 M undefined	-11.27 M undefined
2016	1.92 M undefined	10.39 M undefined	6.63 M undefined
2015	684,000 undefined	-6.93 M undefined	-7.02 M undefined
2014	3.74 M undefined	-3.79 M undefined	-3.75 M undefined
2013	750,000 undefined	-4.05 M undefined	-3.88 M undefined
2012	2.1 M undefined	-7.4 M undefined	-8.04 M undefined
2011	1.5 M undefined	-5.86 M undefined	-3.41 M undefined
2010	1.46 M undefined	-5.22 M undefined	-2.78 M undefined
2009	2.03 M undefined	-3.78 M undefined	-1.63 M undefined
2008	3.58 M undefined	-2.45 M undefined	-390,000 undefined
2007	4.24 M undefined	-530,000 undefined	1.68 M undefined
2006	3.9 M undefined	1.78 M undefined	1.67 M undefined
2005	1.47 M undefined	-2.25 M undefined	-2.09 M undefined
2004	180,000 undefined	-1.11 M undefined	-640,000 undefined

	Revenue	EBIT	Net Income
2004	180,000 EUR	-1.11 M EUR	-640,000 EUR
2005	1.47 M EUR	-2.25 M EUR	-2.09 M EUR
2006	3.9 M EUR	1.78 M EUR	1.67 M EUR
2007	4.24 M EUR	-530,000 EUR	1.68 M EUR
2008	3.58 M EUR	-2.45 M EUR	-390,000 EUR
2009	2.03 M EUR	-3.78 M EUR	-1.63 M EUR
2010	1.46 M EUR	-5.22 M EUR	-2.78 M EUR
2011	1.5 M EUR	-5.86 M EUR	-3.41 M EUR
2012	2.1 M EUR	-7.4 M EUR	-8.04 M EUR
2013	750,000 EUR	-4.05 M EUR	-3.88 M EUR
2014	3.74 M EUR	-3.79 M EUR	-3.75 M EUR
2015	684,000 EUR	-6.93 M EUR	-7.02 M EUR
2016	1.92 M EUR	10.39 M EUR	6.63 M EUR
2017	4.04 M EUR	-11.1 M EUR	-11.27 M EUR
2018	3.31 M EUR	-5.03 M EUR	-6.14 M EUR
2019	350,000 EUR	-8.38 M EUR	-8.25 M EUR
2020	50,000 EUR	-9.65 M EUR	-8.93 M EUR
2021	169.69 M EUR	73.04 M EUR	82.62 M EUR
2022	226.6 M EUR	-43.76 M EUR	-50.83 M EUR
2023e	135.96 M EUR	-31.93 M EUR	-43.01 M EUR
2024e	198.79 M EUR	-10.3 M EUR	-20.45 M EUR
2025e	260.59 M EUR	7.21 M EUR	-4.72 M EUR
2026e	425.9 M EUR	32.16 M EUR	73.14 M EUR

2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022

1.6	5.72	6.35	58.07	55.69	48.8	40.11	26.87	23.2	15.91	10.87	10.67	41.87	33.71	35.19	26.64	18.18	43.28	13.51
0.07	0	0.01	0.04	0.06	0.57	1.07	0.36	1.26	0.39	0.09	0.22	0.2	0.79	0.79	0.73	0.44	40.67	26
0	0	0	0	0	0	0	0	0	0	2.59	2.1	1.69	1.77	1.72	2.62	5.71	5.57	25.21
0.01	0.01	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.17	51.26	47.55
0.2	0.49	1.22	3.16	5.47	7.68	6.28	5.37	4.06	3.69	0.68	0.73	0.42	0.43	0.39	0.6	0.78	2.92	3.63
1.88	6.22	7.58	61.27	61.22	57.05	47.46	32.6	28.52	19.99	14.22	13.73	44.18	36.71	38.09	30.58	25.28	143.7	115.89
0.91	0.9	1.45	4.85	5.59	11.57	15.1	15.11	13.46	11.48	9.53	8.27	6.81	5.68	5.72	17.23	36.93	82.55	86.18
0.01	0.01	0.02	0.04	0.05	0.05	0.02	6.01	0.01	0	1.34	0.02	0	0	0	0	0.1	0.42	0.68
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.76	2.12
1.55	2.86	4.64	8.2	11.11	15.84	20.68	26.55	28.55	33.26	34.46	35.34	22.55	14.98	14.98	14.54	15.39	15.44	14.72
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
2.13	1.98	1.14	1.85	1.27	1.93	3.46	5.25	5.45	5.47	5.52	5.47	2.14	2.17	1.17	1.28	1.25	9.32	6.32
4.6	5.75	7.25	14.94	18.02	29.39	39.26	52.92	47.47	50.21	50.85	49.11	31.49	22.84	21.88	33.04	53.66	109.5	110.02
6.48	11.97	14.83	76.21	79.24	86.44	86.72	85.52	75.99	70.2	65.07	62.84	75.67	59.55	59.96	63.62	78.94	253.19	225.91

0.56	1.31	1.31	2.03	2.04	2.12	2.12	2.22	2.22	2.23	2.23	2.33	2.33	2.33	2.33	2.33	2.78	4.38	4.38
4.2	11.4	11.4	65.23	65.29	65.39	65.4	66.11	66.11	66.12	66.12	71	71	70.96	70.96	70.96	77.31	133.17	133.2
-2.5	-2.26	-0.45	2.65	5.51	4.52	1.81	-1.43	-9.26	-12.99	-16.67	-23.72	-17.09	-27.9	-33.87	-41.91	-50.52	17.86	-33.89
0	0	0	0	0	0	0	10	20	20	2	52	30	21	-20	1	1	0	0
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
2.26	10.45	12.26	69.91	72.84	72.03	69.33	66.91	59.09	55.38	51.67	49.65	56.27	45.42	39.4	31.38	29.56	155.41	103.69
0.26	0.2	0.52	0.59	1.01	1.09	1.43	1.96	1.17	1.54	1.7	1.39	1.56	1.33	1.46	0.94	2.37	44.14	40.61
0	0	0	0	0.84	1.22	1.36	1.66	2.2	1.59	1.34	1.24	1.54	1.18	1.05	1.04	1.37	8.48	13.12
0.22	0.3	0.59	1.78	0.44	2.42	1.18	0.69	1.03	1.23	0.23	2.74	6.65	2.46	2.37	6.62	8.91	7.11	7.26
0	260	240	400	90	10	0	0	10	0	2	3	3	3	2	0	0	0	4
0.2	0.21	0.29	0.41	0.72	3.9	1.67	1.85	1.92	1.99	1.89	1.51	0.93	0.84	0.77	1.06	1.19	4.29	25.78
0.68	0.97	1.64	3.18	3.1	8.64	5.64	6.16	6.33	6.35	5.15	6.88	10.68	5.82	5.65	9.65	13.84	64	86.78
3.54	0.53	0.82	1.09	2.85	5.07	10.77	11.47	9.58	8.41	6.81	6.18	5.97	5.26	5.92	6.69	13.65	24.1	22.08
0	0	0	1.74	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	0	0.1	0.29	0.44	0.69	0.97	0.99	0.98	0.05	1.43	0.12	2.75	3.05	3.14	3.19	3.26	10.01	11.24
3.54	0.53	0.92	3.12	3.29	5.76	11.74	12.46	10.56	8.46	8.24	6.3	8.72	8.31	9.05	9.88	16.91	34.11	33.32
4.22	1.5	2.56	6.3	6.39	14.4	17.38	18.62	16.89	14.81	13.39	13.18	19.41	14.13	14.7	19.53	30.74	98.11	120.1
6.48	11.95	14.82	76.21	79.23	86.43	86.71	85.53	75.98	70.19	65.07	62.84	75.67	59.55	54.1	50.91	60.31	253.53	223.79

2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022
0	-2	1	1	0	-1	-2	-3	-8	-3	-3	-7	6	-11	-6	-8	-9	82	-50
0	0	0	0	0	1	1	2	5	2	2	2	4	9	1	1	0	3	8
0	0	0	0	0	0	-1	-1	0	0	0	0	3	0	1	0	0	-8	3
0	0	0	-1	-1	0	0	2	0	0	0	0	20	-7	1	-1	-2	13	0
0	2	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	-85	1
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	0	2	3	0	-1	-1	0	-1	0	-1	-3	34	-8	-1	-7	-10	4	-38
0	0	0	-4	-2	-8	-6	-2	-1	-7	-2	-2	0	0	-1	-16	-23	-15	-15
0	-1	-1	-6	-5	-10	-10	-15	0	-5	-1	-1	-1	0	4	-1	-11	-57	2
0	-1	-1	-2	-2	-2	-4	-12	1	2	0	0	0	0	6	14	11	-42	18
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	0	0	0	2	5	3	1	-1	0	-1	0	0	0	0	0	7	4	23
0	4	0	54	0	0	0	0	0	0	0	4	0	0	0	0	6	57	0
0	4	0	54	2	5	3	1	-2	-1	-2	3	0	-1	0	0	13	62	21
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-1.00
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
-1	3	0	51	-2	-6	-8	-13	-3	-7	-5	-1	32	-10	3	-8	-8	9	-14
-0.8	0.47	2.32	-0.66	-1.15	-9.82	-7.54	-2.34	-2.8	-8.71	-3.92	-5.82	33.85	-9.19	-2.86	-24.09	-33.89	-11.36	-54.67
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

Metabolic Explorer Gross margin	Metabolic Explorer Profit margin	Metabolic Explorer EBIT margin	Metabolic Explorer Profit margin
2026e	-0.63 %	7.55 %	17.17 %
2025e	-0.63 %	2.77 %	-1.81 %
2024e	-0.63 %	-5.18 %	-10.29 %
2023e	-0.63 %	-23.48 %	-31.63 %
2022	-0.63 %	-19.31 %	-22.43 %
2021	9.44 %	43.04 %	48.69 %
2020	-3,324 %	-19,304 %	-17,864 %
2019	-0.63 %	-2,393.43 %	-2,355.71 %
2018	-0.63 %	-152.03 %	-185.49 %
2017	-0.63 %	-274.92 %	-279.08 %
2016	-0.63 %	541.48 %	345.34 %
2015	-0.63 %	-1,012.87 %	-1,026.17 %
2014	-0.63 %	-101.31 %	-100.13 %
2013	-0.63 %	-540 %	-517.33 %
2012	-0.63 %	-352.38 %	-382.86 %
2011	-0.63 %	-390.67 %	-227.33 %
2010	-0.63 %	-357.53 %	-190.41 %
2009	-0.63 %	-186.21 %	-80.3 %
2008	-0.63 %	-68.44 %	-10.89 %
2007	-0.63 %	-12.5 %	39.62 %
2006	-0.63 %	45.64 %	42.82 %
2005	-0.63 %	-153.06 %	-142.18 %
2004	-0.63 %	-616.67 %	-355.56 %

	Gross margin	EBIT margin	Profit margin
2004	-0.63 %	-616.67 %	-355.56 %
2005	-0.63 %	-153.06 %	-142.18 %
2006	-0.63 %	45.64 %	42.82 %
2007	-0.63 %	-12.5 %	39.62 %
2008	-0.63 %	-68.44 %	-10.89 %
2009	-0.63 %	-186.21 %	-80.3 %
2010	-0.63 %	-357.53 %	-190.41 %
2011	-0.63 %	-390.67 %	-227.33 %
2012	-0.63 %	-352.38 %	-382.86 %
2013	-0.63 %	-540 %	-517.33 %
2014	-0.63 %	-101.31 %	-100.13 %
2015	-0.63 %	-1,012.87 %	-1,026.17 %
2016	-0.63 %	541.48 %	345.34 %
2017	-0.63 %	-274.92 %	-279.08 %
2018	-0.63 %	-152.03 %	-185.49 %
2019	-0.63 %	-2,393.43 %	-2,355.71 %
2020	-3,324 %	-19,304 %	-17,864 %
2021	9.44 %	43.04 %	48.69 %
2022	-0.63 %	-19.31 %	-22.43 %
2023e	-0.63 %	-23.48 %	-31.63 %
2024e	-0.63 %	-5.18 %	-10.29 %
2025e	-0.63 %	2.77 %	-1.81 %
2026e	-0.63 %	7.55 %	17.17 %

Date	Metabolic Explorer Sales per Share	Metabolic Explorer EBIT per share	Metabolic Explorer Earnings per Share
2026e	8.36 undefined	0 undefined	1.44 undefined
2025e	5.12 undefined	0 undefined	-0.09 undefined
2024e	3.9 undefined	0 undefined	-0.4 undefined
2023e	2.67 undefined	0 undefined	-0.84 undefined
2022	5.07 undefined	-0.98 undefined	-1.14 undefined
2021	4.53 undefined	1.95 undefined	2.21 undefined
2020	0 undefined	-0.35 undefined	-0.32 undefined
2019	0.01 undefined	-0.35 undefined	-0.35 undefined
2018	0.14 undefined	-0.21 undefined	-0.26 undefined
2017	0.17 undefined	-0.47 undefined	-0.48 undefined
2016	0.07 undefined	0.37 undefined	0.24 undefined
2015	0.03 undefined	-0.3 undefined	-0.3 undefined
2014	0.17 undefined	-0.17 undefined	-0.17 undefined
2013	0.03 undefined	-0.18 undefined	-0.17 undefined
2012	0.09 undefined	-0.33 undefined	-0.36 undefined
2011	0.07 undefined	-0.28 undefined	-0.16 undefined
2010	0.07 undefined	-0.25 undefined	-0.13 undefined
2009	0.1 undefined	-0.18 undefined	-0.08 undefined
2008	0.18 undefined	-0.12 undefined	-0.02 undefined
2007	0.21 undefined	-0.03 undefined	0.08 undefined
2006	0.19 undefined	0.09 undefined	0.08 undefined
2005	0.07 undefined	-0.11 undefined	-0.1 undefined
2004	0.01 undefined	-0.05 undefined	-0.03 undefined

	Sales per Share	EBIT per share	Earnings per Share
2004	0.01 EUR	-0.05 EUR	-0.03 EUR
2005	0.07 EUR	-0.11 EUR	-0.1 EUR
2006	0.19 EUR	0.09 EUR	0.08 EUR
2007	0.21 EUR	-0.03 EUR	0.08 EUR
2008	0.18 EUR	-0.12 EUR	-0.02 EUR
2009	0.1 EUR	-0.18 EUR	-0.08 EUR
2010	0.07 EUR	-0.25 EUR	-0.13 EUR
2011	0.07 EUR	-0.28 EUR	-0.16 EUR
2012	0.09 EUR	-0.33 EUR	-0.36 EUR
2013	0.03 EUR	-0.18 EUR	-0.17 EUR
2014	0.17 EUR	-0.17 EUR	-0.17 EUR
2015	0.03 EUR	-0.3 EUR	-0.3 EUR
2016	0.07 EUR	0.37 EUR	0.24 EUR
2017	0.17 EUR	-0.47 EUR	-0.48 EUR
2018	0.14 EUR	-0.21 EUR	-0.26 EUR
2019	0.01 EUR	-0.35 EUR	-0.35 EUR
2020	0 EUR	-0.35 EUR	-0.32 EUR
2021	4.53 EUR	1.95 EUR	2.21 EUR
2022	5.07 EUR	-0.98 EUR	-1.14 EUR
2023e	2.67 EUR	0 EUR	-0.84 EUR
2024e	3.9 EUR	0 EUR	-0.4 EUR
2025e	5.12 EUR	0 EUR	-0.09 EUR
2026e	8.36 EUR	0 EUR	1.44 EUR

	Number of stocks
2004	20.22 M Aktien
2005	20.22 M Aktien
2006	20.22 M Aktien
2007	20.42 M Aktien
2008	20.3 M Aktien
2009	20.89 M Aktien
2010	20.89 M Aktien
2011	21.22 M Aktien
2012	22.21 M Aktien
2013	22.23 M Aktien
2014	22.26 M Aktien
2015	23.16 M Aktien
2016	28.08 M Aktien
2017	23.62 M Aktien
2018	23.82 M Aktien
2019	23.82 M Aktien
2020	27.88 M Aktien
2021	37.45 M Aktien
2022	44.69 M Aktien
2023e	44.69 M Aktien
2024e	44.69 M Aktien
2025e	44.69 M Aktien
2026e	44.69 M Aktien

%	Name	Stocks	Change	Date
31.04227 %	Bpifrance Investissement	15,806,724	-206,198	12/14/2023
0.96969 %	Edmond de Rothschild Asset Management (France) S.A.	493,768	-3	6/30/2024
0.27015 %	HSBC Global Asset Management (France) S.A.	137,559	0	7/31/2024
0.08837 %	ACA Asset management Company & Associ¿s	45,000	0	11/30/2023
0.00970 %	Edmond De Rothschild Asset Management (Luxembourg)	4,937	3	6/30/2024
0 %	Mirova	0	-60,538	2/29/2024
0 %	Dimensional Fund Advisors, Ltd.	0	-8,768	10/31/2023
0 %	FPM Frankfurt Performance Management AG	0	-180,000	3/31/2024
0 %	Advisory Invest GmbH	0	-487,740	3/31/2024
0 %	La Française AM	0	-815,870	3/31/2024
0 %	Portzamparc Gestion S.A.	0	-210,000	8/31/2023
0 %	Credit Mutuel Asset Management	0	-815,870	3/31/2024
0 %	Generali Investments Partners S.p.A. SGR	0	-9,683	4/30/2023

Name	Relationship	Two-week correlation	One-month correlation	Three-Month Correlation	Six-Month Correlation	One Year Correlation	Two-Year Correlation
Koninklijke DSM	SupplierCustomer	-0,24	-0,60	0,22	0,73	0,58	0,78
UPM-Kymmene	SupplierCustomer	-0,28	0,38	0,74	0,81	0,23	0,83

What values and corporate philosophy does Metabolic Explorer represent?

Metabolic Explorer SA, a leading company in the stock market, embodies strong values and a distinctive corporate philosophy. With a focus on sustainability and innovation, the company aims to leverage bio-manufacturing technologies for the production of sustainable chemicals. Metabolic Explorer SA is committed to addressing global challenges in the chemical industry through eco-friendly processes and cost-effective solutions. By prioritizing research and development, the company strives to optimize its production processes and enhance the value of its products. Metabolic Explorer SA's corporate philosophy encompasses responsible and ethical practices, fostering a strong commitment to environmental stewardship and societal development. As a result, investors can rely on Metabolic Explorer SA's alignment with sustainable strategies and dedication towards a greener future.

In which countries and regions is Metabolic Explorer primarily present?

Metabolic Explorer SA is primarily present in France, where the company is headquartered. It operates its manufacturing plant and research center in the region of Normandy. Additionally, the company has a global presence and actively seeks growth opportunities in other countries and regions. With a focus on sustainable chemistry and bio-based solutions, Metabolic Explorer SA aims to expand its reach and establish strategic partnerships worldwide. This French company's innovative approach has garnered international attention, making it an influential player in the global chemical industry.

What significant milestones has the company Metabolic Explorer achieved?

Metabolic Explorer SA has achieved several significant milestones. The company successfully commercialized its first product, PDO, and established strategic partnerships for its global distribution. Metabolic Explorer SA also obtained regulatory approval for PDO's commercial production in its Pomacle facility. Furthermore, the company expanded its product portfolio by developing a bio-sourced substitute for butyric acid. Metabolic Explorer SA demonstrated its commitment to sustainability by using renewable raw materials and eco-friendly processes. With continual advancements, Metabolic Explorer SA has positioned itself as a key player in the sustainable chemicals industry.

What is the history and background of the company Metabolic Explorer?

Metabolic Explorer SA is a company with a rich history and background. Established in France, Metabolic Explorer SA has become a leading player in the biotech industry. Founded in 1999, the company specializes in developing sustainable fermentation-based processes for the production of various compounds. Metabolic Explorer SA utilizes its proprietary technologies to manufacture high-value chemicals, such as biosourced alternatives to petrochemicals. With a strong emphasis on sustainability and eco-friendly solutions, Metabolic Explorer SA aims to revolutionize the chemical industry. This company has achieved significant milestones and continues to innovate, making substantial contributions to a more sustainable future.

Who are the main competitors of Metabolic Explorer in the market?

The main competitors of Metabolic Explorer SA in the market include various companies operating in the biochemical and green chemistry sector. Some prominent competitors are Amyris Inc., Avantium NV, Genomatica Inc., and Evogene Ltd. These companies engage in similar activities as Metabolic Explorer SA, such as developing and producing renewable chemicals, bio-based materials, and sustainable solutions. As Metabolic Explorer SA aims to revolutionize the chemical industry with its innovative technologies and sustainable processes, it competes with these industry players to establish a strong market presence and capture a sizeable market share.

In which industries is Metabolic Explorer primarily active?

Metabolic Explorer SA is primarily active in the industries of biotechnology, chemicals, and sustainable manufacturing.

What is the business model of Metabolic Explorer?

The business model of Metabolic Explorer SA revolves around developing and commercializing sustainable biochemicals for various industries. With a focus on the production of organic acids, the company utilizes its proprietary technologies to transform renewable resources into high-value products. By leveraging their expertise in metabolic engineering and bioprocess optimization, Metabolic Explorer aims to provide cost-effective and eco-friendly alternatives to petrochemical-based products. Through strategic collaborations and licensing agreements, the company aims to expand its market presence and drive growth in the bioplastics, textiles, and animal nutrition sectors, contributing to a more sustainable and environmentally conscious future.

What is the P/E ratio of Metabolic Explorer 2024?

The Metabolic Explorer P/E ratio is -0.27.

What is the P/S ratio of Metabolic Explorer 2024?

The Metabolic Explorer P/S ratio is 0.03.

What is the Quality Investing of Metabolic Explorer?

The Quality Investing for Metabolic Explorer is 5/10.

What is the revenue of Metabolic Explorer 2024?

The expected Metabolic Explorer revenue is 198.79 M EUR.

How high is the profit of Metabolic Explorer 2024?

The expected Metabolic Explorer profit is -20.45 M EUR.

What is the business model of Metabolic Explorer

Metabolic Explorer SA (METEX) is an innovative biotech company specializing in the production of biological chemicals and components. The company is headquartered in France and has additional locations in Germany and the USA. METEX operates in two business areas: Metabolic Engineering and Bio-Industrial Solutions. In the Metabolic Engineering sector, the company provides platforms and technologies that allow customers to optimize biological metabolic pathways and produce customized chemical products. METEX also offers services such as genome analysis and identification of gene mutations that can enhance the production of desired chemicals. The company specializes particularly in the production of biosuccinic acid, an important intermediate used in the production of plastics, adhesives, and solvents. In the Bio-Industrial Solutions sector, METEX specializes in the commercial production of chemical products from biological resources. The company utilizes a variety of microbial metabolic pathways to produce bio-based chemicals such as butylene and propanediol, isobutanol, and L-lactic acid. These products are used as raw materials for the production of plastics, textiles, cosmetics, and other products that typically rely on petrochemical resources. METEX has formed partnerships with numerous companies and research institutions worldwide to further develop and improve its technologies and products. The company maintains long-term partnerships with major chemical companies such as BASF and Roquette to integrate its processes and products into larger applications. METEX strives to make its products and technologies as sustainable as possible. The company actively advocates for a circular economy and promotes the development of bio-based products and packaging that are reusable and recyclable. METEX is a member of the European Bioplastics Association and is dedicated to a more sustainable future. In summary, METEX is a biotech company specializing in the production of bio-based chemicals and components. The company operates in two business areas, Metabolic Engineering and Bio-Industrial Solutions, and offers a wide range of services and products. METEX works closely with its customers and partners to develop innovative and sustainable solutions that meet the needs of the industry and society.

What is the Metabolic Explorer dividend?

Metabolic Explorer pays a dividend of 0 EUR distributed over payouts per year.

How often does Metabolic Explorer pay dividends?

The dividend cannot currently be calculated for Metabolic Explorer or the company does not pay out a dividend.

What is the Metabolic Explorer ISIN?

The ISIN of Metabolic Explorer is FR0004177046.

What is the Metabolic Explorer WKN?

The WKN of Metabolic Explorer is A0MN12.

What is the Metabolic Explorer ticker?

The ticker of Metabolic Explorer is METEX.PA.

How much dividend does Metabolic Explorer pay?

Over the past 12 months, Metabolic Explorer paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Metabolic Explorer is expected to pay a dividend of 0 EUR.

What is the dividend yield of Metabolic Explorer?

The current dividend yield of Metabolic Explorer is .

When does Metabolic Explorer pay dividends?

Metabolic Explorer pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Metabolic Explorer?

Metabolic Explorer paid dividends every year for the past 0 years.

What is the dividend of Metabolic Explorer?

For the upcoming 12 months, dividends amounting to 0 EUR are expected. This corresponds to a dividend yield of 0 %.

In which sector is Metabolic Explorer located?

Metabolic Explorer is assigned to the 'Commodities' sector.

Wann musste ich die Aktien von Metabolic Explorer kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Metabolic Explorer from 12/18/2024 amounting to 0 EUR, you needed to have the stock in your portfolio before the ex-date on 12/18/2024.

When did Metabolic Explorer pay the last dividend?

The last dividend was paid out on 12/18/2024.

What was the dividend of Metabolic Explorer in the year 2023?

In the year 2023, Metabolic Explorer distributed 0 EUR as dividends.

In which currency does Metabolic Explorer pay out the dividend?

The dividends of Metabolic Explorer are distributed in EUR.

Stock Exchange	Metabolic Explorer Ticker
EURONEXT	METEX.PA
FRANKFURT	7ME.F
LONDON	0GT7.L
MUNICH	7ME.MU
PARIS	METEX.PA

Metabolic Explorer Ticker	Metabolic Explorer FIGI
METEX:FP	BBG000LYJB60
METEX:EU	BBG000RPNZL8
METEX:EO	BBG000RPNZX5
METEX:XH	BBG000RPP0Q8
METEX:XC	BBG000RPP0X0
METEX:XF	BBG000RPP122
METEX:XE	BBG000RPP1S4
METEX:XJ	BBG000RPP211
METEX:XL	BBG000RPP257
METEX:XG	BBG000RPP2N7
METEX:XO	BBG000RPP319
METEX:XS	BBG000RPP499
METEX:XA	BBG000RPP4K6
METEX:E1	BBG000RPP4W3
METEX:XT	BBG000RPP541
METEX:XW	BBG000RPP5N0
METEXP:TQ	BBG000VMD5Q2
METEXP:BQ	BBG000VWB4V9
METEXP:EB	BBG001818ZN5
METEXP:S1	BBG001MBZBG8
METEXP:IX	BBG002GCYXH3
METEX:XV	BBG00591C2G1
METEXP:B3	BBG006T6V3J0
METEXP:L3	BBG006TB02F9
METEXP:PO	BBG008H04P58
7ME:GR	BBG00BFJ5DP6
7ME:GF	BBG00BFJ5DQ5
7ME:GM	BBG00BFJ5DV9
METEX:XM	BBG00J9VH0R2
METEX:XX	BBG00JN78QD7
METEXP:T1	BBG00NLK70K1
METEXP:I2	BBG00NQCPMJ8
0GT7:LN	BBG00NRVX987
METEXP:L1	BBG00Y9244T7
METEXP:S4	BBG00YJ7YYH9
METEXGBP:XS	BBG00Z6B7B72
METEXGBP:XH	BBG00Z6B7BB7
METEXGBP:XF	BBG00Z6B7BD5
METEXGBP:XE	BBG00Z6B7BG2
METEXGBP:XL	BBG00Z6B7BJ9
METEXGBP:XG	BBG00Z6B7BK7
METEXGBP:XO	BBG00Z6B7BL6
METEXGBP:XA	BBG00Z6B7BQ1
METEXGBP:XT	BBG00Z6B7BS9
METEXGBP:XW	BBG00Z6B7BT8
METEXGBP:XU	BBG00Z6B7BV5
METEXGBP:XV	BBG00Z6B7BX3
METEXGBP:XM	BBG00Z6B7BY2
METEXGBP:EU	BBG00Z6B7C52
7ME:GZ	BBG0146V2ZM1
METEXP:QX	BBG016H83032
METEXP:QE	BBG016H8LW41
7ME:LA	BBG018H9FC73
7ME:LU	BBG018J32CZ7
METEXUSD:EO	BBG01F7JM387
METEXUSD:X2	BBG01F7JM396
METEXUSD:XH	BBG01F7JM3C2
METEXUSD:XF	BBG01F7JM3F9
METEXUSD:XE	BBG01F7JM3H7
METEXUSD:XJ	BBG01F7JM3J5
METEXUSD:XL	BBG01F7JM3K3
METEXUSD:XG	BBG01F7JM3L2
METEXUSD:XO	BBG01F7JM3M1
METEXUSD:XA	BBG01F7JM3R6
METEXUSD:E1	BBG01F7JM3S5
METEXUSD:XT	BBG01F7JM3T4
METEXUSD:XW	BBG01F7JM3V1
METEXUSD:XU	BBG01F7JM3W0
METEXUSD:XY	BBG01F7JM3X9
METEXUSD:XV	BBG01F7JM3Y8
METEXUSD:XM	BBG01F7JM3Z7
METEXUSD:XQ	BBG01F7JM403
METEXUSD:XX	BBG01F7JM412
METEXUSD:XZ	BBG01F7JM421
METEXUSD:X1	BBG01F7JM449
METEXUSD:EU	BBG01F7JM467

2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023e	2024e	2025e	2026e
0	1	3	4	3	2	1	1	2	0	3	0	1	4	3	0	0	169	226	135	198	260	425
-	-	200.00	33.33	-25.00	-33.33	-50.00	-	100.00	-	-	-	-	300.00	-25.00	-	-	-	33.73	-40.27	46.67	31.31	63.46
-	-100.00	-33.33	-25.00	-33.33	-50.00	-100.00	-100.00	-50.00	-	-33.33	-	-100.00	-25.00	-33.33	-	-	9.47	-0.44	-0.74	-0.51	-0.38	-0.24
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-1	16	-1	0	0	0	0
0	-2	1	1	0	-1	-2	-3	-8	-3	-3	-7	6	-11	-6	-8	-8	82	-50	-43	-20	-4	73
-	-	-150.00	-	-	-	100.00	50.00	166.67	-62.50	-	133.33	-185.71	-283.33	-45.45	33.33	-	-1,125.00	-160.98	-14.00	-53.49	-80.00	-1,925.00
20.22	20.22	20.22	20.42	20.3	20.89	20.89	21.22	22.21	22.23	22.26	23.16	28.08	23.62	23.82	23.82	27.88	37.45	44.69	0	0	0	0
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

Access the world's leading financial data and tools

Price

Price

TickerMETEX.PA

ISINFR0004177046

WKNA0MN12

Metabolic Explorer stock price

Price

Overview

Intraday Feature

Total Return and Relative Price Change

Interpretation and Investment

Metabolic Explorer Stock Price History

Metabolic Explorer Revenue, EBIT, Net Income FR0004177046 · A0MN12

Revenue, EBIT and Profit

Understanding Revenue, EBIT, and Income

Yearly Analysis and Comparisons

Utilizing Expectations for Investment

Investment Insights

Metabolic Explorer Revenue, EBIT and net profit per share

Metabolic Explorer Income Statement, Balance Sheet, Cash Flow Statement

Keystats

Revenue and Growth

Gross Margin

EBIT and EBIT Margin

Income and Growth

Shares Outstanding

Interpreting Year to Year Comparison

Expectations and Predictions

Balance Sheet

Understanding the Balance Sheet

Assets

Liabilities

Equity

Year-to-Year Analysis

Interpreting the Data

Metabolic Explorer stock margins FR0004177046 · A0MN12

Margin

Understanding Gross Margin

EBIT Margin Analysis

Revenue Margin Insights

Interpreting Expectations

Comparative Analysis

Metabolic Explorer Margin History

Metabolic Explorer Stock Sales Revenue, EBIT, Earnings per Share FR0004177046 · A0MN12

Revenue, EBIT and Earnings per share

Revenue Per Share

EBIT Per Share

Income Per Share

Expected Values

Metabolic Explorer Revenue, EBIT and net profit per share

Metabolic Explorer business model

Metabolic Explorer SWOT Analysis

Strengths

Weaknesses

Opportunities

Threats

The World’s Best Investors Are On Eulerpool

Metabolic Explorer Eulerpool Fair Value

Fair Value

Understanding Fair Value

Income-Based Fair Value

Revenue-Based Fair Value

Dividend-Based Fair Value

Expectations and Forecasts

Comparative Analysis

Metabolic Explorer historical P/E ratio, EBIT multiple, and P/S ratio

The World’s Best Investors Are On Eulerpool

Metabolic Explorer shares outstanding FR0004177046 · A0MN12

Revenue, EBIT and Earnings per share

Revenue Per Share

EBIT Per Share

Income Per Share

Expected Values

The World’s Best Investors Are On Eulerpool

Metabolic Explorer Earnings Estimates

Metabolic Explorer latest earnings and earnings surprises

Metabolic Explorer shareholders

Metabolic Explorer Executives and Management Board

Dr. Benjamin Gonzalez

Ticker
METEX.PA

ISIN
FR0004177046

WKN
A0MN12